Skip to content

Cerebral Embolic Load in Patients Undergoing Surgical Aortic Valve Replacement: A Comparison of the Conventional With the Minimized Extracorporeal Circulation Technique Using Transcranial Doppler Ultrasound

Aortic Valve Replacement Using Closed Extracorporeal Circuit. Minimized Versus Conventional Extracorporeal Circulation Technique: Qualitative Differences

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02308566
Acronym
AKE-MECC
Enrollment
48
Registered
2014-12-04
Start date
2011-06-30
Completion date
2016-06-30
Last updated
2016-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Stenosis, Extracorporeal Circulation

Keywords

Intracranial Embolism, Ultrasonography, Doppler, Transcranial

Brief summary

In this study, the investigators aim to compare cerebral embolic load in patients undergoing surgical aortic valve replacement using either the minimized extracorporeal circulation or the conventional extracorporeal circulation technique. The detection of cerebral emboli is performed not-invasively by transcranial Doppler detection of high-intensity transient signals representing solid or gaseous microembolism in the middle cerebral arteries. The investigators hope to get more insight in the mechanism (incl. quantity) of cerebral embolism during aortic valve surgery using extracorporeal circulation.

Detailed description

Background The gold standard to treat severe aortic valve stenosis is currently the surgical aortic valve replacement (SAVR) using conventional extracorporeal circulation (CECC). SAVR, however, can be performed also on minimized extracorporeal circulation (MECC), which is characterized by reduced priming volume and interfaces between blood and artificial surfaces and blood-air interface, respectively. Further technical developments of the MECC system together with reports on less induction of the coagulation cascade and activation of inflammatory systemic response may account for a reduced incidence of microbubble generation with MECC system. Objective The aim of the is to investigate the procedural-related incidence of high-intensity transient signals (HITS) representing solid or gaseous microembolism reaching the cerebral vessels. Methods Patients undergoing SAVR are included in the study and randomised to either MECC or CECC technique. HITS are continuously bilaterally detected during the entire intraoperative period by transcranial Doppler ultrasound.

Interventions

PROCEDUREMinimized Extracorporeal Circulation (MECC)

This group of patients receives surgical aortic valve replacement using MECC.

This group of patients receives surgical aortic valve replacement using CECC.

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Isolated Severe Aortic Valve Stenosis * No other cardiac disease * No other coronary heart disease * Written informed consent

Exclusion criteria

* Double valve surgery * Concomitant coronary artery bypass surgery * Vascular surgery * Age \< 18 yrs. * Age \> 80 yrs.

Design outcomes

Primary

MeasureTime frame
Total and interval-related cerebral microembolic load as measured by transcranial DopplerIntraoperative period (start surgical procedure to skin suture, duration approx. 4 hrs)

Secondary

MeasureTime frame
In-hospital MortalityIn-hospital period (until hospital discharge, duration approx. 7-10 days)
Cerebral complications, e.g. delirium and stroke as detected clinicallyIn-hospital period (until hospital discharge, duration approx. 7-10 days)
Redo surgeryIn-hospital period (until hospital discharge, duration approx. 7-10 days)
In-hospital infectionsIn-hospital period (until hospital discharge, duration approx. 7-10 days)
Extubation timeIn-hospital period (until hospital discharge, duration approx. 7-10 days)
Thromboembolic complicationsIn-hospital period (until hospital discharge, duration approx. 7-10 days)
ICU length of stayIn-hospital period (until hospital discharge, duration approx. 7-10 days)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026